Company intelligence / Profile preview

Nucleics

Woollahra, New South Wales, Australia

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Nucleics is an Australian private life science tools company focused on improving DNA sequencing workflows through software, reagents, and sequencing-related services. Founded in 1999, the company develops products for Sanger sequencing, including the PeakTrace basecaller platform, trace-processing tools, and cost-reduction reagents such as dLUTE SEQ. Nucleics also provides DNA sequencing support, bioinformatics consulting, and genomics-related services for research customers and core facilities. Its business appears centered on commercialized sequencing workflow products rather than therapeutic drug development.

Modalities: Synthetic oligonucleotideReagentSoftwareService
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Nucleics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleics.

Explore the full profile